LabCompass

Spencer D. Lindeman

Medicine · Purdue University West Lafayette

Mid career · publishing since 2003

Publications

11

Citations

343

Est. group size

~5

Recurring co-author estimate

Active years

22

Publishing since 2003

Research summary
AI-generated

Spencer D. Lindeman's research is associated with topics in medicine, including cardiac structural conditions, lung diseases, diabetes management, and enzyme-related analysis, with a recent publication describing a radioligand therapy (a radioactive-molecule based treatment) targeting a protein called FAP for cancer treatment in animal models. The limited public data available suggests work at the intersection of experimental cancer therapeutics and other medical topics, though the exact scope and focus areas are not fully clear from the available record.

Cancer radioligand therapyCardiac structural conditionsLung disease researchDiabetes managementEnzyme (peptidase) inhibition

Publication output has been low and irregular over the last decade, with sporadic years of activity (e.g., 2019, 2020, 2022, 2024) interspersed with years of no recorded output.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 1.0/year recently
17182019: 1 publication192020: 3 publications320212022: 2 publications22232024: 3 publications3242526
Publishes in
  • Journal of Nuclear Medicine×2
  • EMBO Molecular Medicine×1
  • Science Translational Medicine×1
  • Journal of Materials Chemistry B×1
  • Journal of Medicinal Chemistry×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 20, 2026.

Claim or correct this profile